Wearable Health Financials
| WHSI Stock | USD 0.0001 0.00 0.00% |
Wearable |
Understanding current and past Wearable Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Wearable Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Wearable Health's assets may result in an increase in income on the income statement.
Wearable Health Stock Summary
Wearable Health competes with GlucoTrack, Sharps Technology, Utah Medical, Innovative Eyewear, and Microbot Medical. Wearable Health Solutions, Inc. provides mobile health products and services in the United States, Canada, New Zealand, and Bermuda. Wearable Health Solutions, Inc. was incorporated in 2008 and is headquartered in Newport Beach, California. Wearable Health operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US94703Q1058 |
| Business Address | 2901 Pacific Coast |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.wearablehealthsolutions.com |
| Phone | 949 270 7460 |
| Currency | USD - US Dollar |
Wearable Health Key Financial Ratios
Wearable Health's financial ratios allow both analysts and investors to convert raw data from Wearable Health's financial statements into concise, actionable information that can be used to evaluate the performance of Wearable Health over time and compare it to other companies across industries.Wearable Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wearable Health's current stock value. Our valuation model uses many indicators to compare Wearable Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wearable Health competition to find correlations between indicators driving Wearable Health's intrinsic value. More Info.Wearable Health Solutions is rated third in return on asset category among its peers. It is rated fourth in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wearable Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wearable Health's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Wearable Health Solutions Systematic Risk
Wearable Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Wearable Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Wearable Health Solutions correlated with the market. If Beta is less than 0 Wearable Health generally moves in the opposite direction as compared to the market. If Wearable Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Wearable Health Solutions is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Wearable Health is generally in the same direction as the market. If Beta > 1 Wearable Health moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Wearable Pink Sheet analysis
When running Wearable Health's price analysis, check to measure Wearable Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wearable Health is operating at the current time. Most of Wearable Health's value examination focuses on studying past and present price action to predict the probability of Wearable Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wearable Health's price. Additionally, you may evaluate how the addition of Wearable Health to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |